Top 15 Life Science VC (Venture Capital) Funds in Austria in November 2024
A list of 15 VC (Venture Capital) funds that invest in Life science startups based in Austria. We rank investors based on the number of investments they made in Life science companies from Austria. We update this investor list every month.Top 15 Life Science VC (Venture Capital) Funds in Austria in November 2024
Investor | Life Science Austria investments |
---|---|
xista science ventures | 3 |
xista science ventures | 3 |
APEX Ventures | 2 |
R42 Group | 2 |
Longevitytech.fund | 2 |
Nina Capital | 2 |
NovaCapital | 1 |
tecnet equity | 1 |
FastVentures | 1 |
SOSV | 1 |
HCVC | 1 |
Pace Ventures | 1 |
Polaris Partners | 1 |
OrbiMed | 1 |
Lansdowne Investment Company Cyprus | 1 |
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Medical Device
- Seed, Pre-Seed, Series A
- Austria, France, Slovenia
Portfolio highlights
- Syntropic — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Funding Round
- Germany, United Kingdom, Austria
Portfolio highlights
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
- CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Funding Round, Pre-Seed
- United Kingdom, United States, Austria
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
- Biotechnology, Health Care, Personal Health
- Seed, Convertible Note, Pre-Seed
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Pre-Seed, Series A
- Italy, Austria
Portfolio highlights
- ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
- Newarc srl — With the help of technology, we simplify and improve the home buying and selling process.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Orderlion is aiming to become the gold standard for online ordering of restaurants & hotels from all their suppliers. Orderlion is already available in more than 20 cities in Austria, Germany, the Czech Republic, Switzerland and France with over 1.000 restaurants and hundreds of suppliers.Orderlion was designed for all types of hospitalitybusinesses (café, restaurant, hotel, chain). The order platform combines all suppliers and products in one app and enables customer-specific pricing. With little effort, the entire inventory of restaurants can be recorded and activated for automatic ordering processes. Orderlion counts numerous prominent restaurants among its customers. Orderlion was founded by Stefan Strohmer and Patrick Schubert in 2018 and has its headquarters in Vienna, Austria.
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
venture capital
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Series B
- Hungary, South Korea, United States
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more
Investment focus
- Software, Artificial Intelligence, Robotics
- Seed, Series A, Pre-Seed
- United States, France, United Kingdom
Portfolio highlights
- Cowboy — Meet Cowboy, the connected electric bike for urban riders. With an intuitive motor to sense your pedaling force and a companion app in the cockpit to guide your ride, tune into a newfound freedom in the city.
- atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
- Surge — PreCyte integrates high-resolution immune system exploration with predictive information to develop preventive strategies, treatments, medical devices.
Life Science & DeepTech Fund
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Funding Round, Pre-Seed
- United States, Germany, Austria
Portfolio highlights
- Clearly.Earth — Mobility Emission Management
- Turnover Labs — Turnover Labs strives to decarbonize the chemical production business and transform how the world generates petrochemicals.
- Dunia Innovation — Catalysing the energy transition.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- United States, Singapore, Ireland
Portfolio highlights
- Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
- Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.
- Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- enGene — enGene is a developer of a mucosal immunotherapy platform designed to treat inflammatory bowel disease and diabetes. The company's mucosal immunotherapy platform has developed a flexible nucleotide delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expressionlevels, enabling physicians and doctors to regenerate physiologic, meal-regulated insulin secretion from the gut of subjects with diabetes.
- Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
- Lomond Therapeutics — Lomond Therapeutics is a pharmaceutical firm that discovers and develops small molecule inhibitors that target escape variants in hematologic malignancies.
Lansdowne Investment Company Cyprus
Show more
Investment focus
- Life Science, Biotechnology, Semiconductor
- Seed
- Austria
Portfolio highlights
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Investors by industry
Health Care
Google
Gaming
Climate
Energy
Community
Marketplace
Hardware
Biotech
Consumer
Proptech
Artificial intelligence
FinTech
Impact
EdTech
Sustainability
Venture Capital
Fashion
Big Data
Finance
Web3
B2B
Beauty
Retail
Education
Clean Energy
Oil and Gas
Food and Beverage
Real Estate
Video Games
Payments
Infrastructure
Photography
Financial Services
Organic Food
Publishing
Social Media
Social Network
Wellness
Enterprise Software
Medical
Android
Digital Media
Music
Legal
Franchise
Local
Internet
Construction
Sports
eSports
Manufacturing
Email
Mobile
Art
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Platforms
Cannabis
Mobile Advertising
Medical Device
Automotive
Wine And Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Theatre
Film
Life Science
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
India
Canada
South Korea
Australia
Ireland
New Zealand
United States
Africa
Vietnam
Saudi Arabia
Japan
South Africa
Europe
Oceania
LATAM
Indonesia
Middle East
Asia
Sri Lanka
China
Singapore
Brazil
Armenia
Qatar
Spain
Chile
Belgium
France
Belarus
Egypt
Ghana
Croatia
Ethiopia
Costa Rica
Gibraltar
Greece
Finland
Belize
Denmark
Hong Kong
Barbados
Bahrain
Hungary
Georgia
Bermuda
Czech Republic
Ecuador
Bulgaria
Algeria
Estonia
Faroe Islands
Kenya
Lithuania
Liechtenstein
Panama
Myanmar
Lebanon
Cayman Islands
Mexico
Philippines
Mali
Norway
Malta
Israel
Italy
Kazakhstan
Cambodia
Peru
Kuwait
Malaysia
Nicaragua
Liberia
Mauritius
Morocco
Jersey
Slovenia
Thailand
Uzbekistan
Serbia
Dominican Republic
Zimbabwe
Sierra Leone
Zambia
Venezuela
Taiwan
Iraq
Bahamas
Togo
Azerbaijan
Portugal
Nigeria
Iceland
Namibia
Turkey
United Arab Emirates
Seychelles
Honduras
San Marino
Uganda
Rwanda
Bolivia
Uruguay
Isle of Man
Luxembourg
Ukraine
Sweden
Pakistan
Senegal
Albania
Tanzania
Tunisia
Russian Federation
El Salvador
Poland
Puerto Rico
Tajikistan
Argentina
Jordan
Bangladesh
Grenada
Romania
Cameroon
Oman
Cyprus
Latvia
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
VC (Venture Capital) Funds in Austria by industry
Media (entertainment)
Transportation
Big Data
Education
Finance
Food and Beverage
Payments
Organic Food
Medical Device
Wellness
Internet
Manufacturing
Mobile
Android
Blockchain
Local
Software
Enterprise Software
Sports
eSports
Fitness
Automotive
Hospitality
Travel
Platforms
Recruiting
FinTech
Biotechnology
Enterprise
Consumer
Real Estate
Health Care
Biotech
EdTech
Energy
Climate
Impact
Marketplace
SaaS
Artificial intelligence
Community
Hardware
Gaming
Mobile Apps
Web3
Life Science
Renewable Energy
Financial Services
Medical
Music
Construction
Cryptocurrency
InsurTech
Social Media
CleanTech
Retail
Sustainability
Proptech